Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Infinity Pharmaceuti (INFI)

1.18   0 (0%) 10-23 23:41
Open: 1.18 Pre. Close: 1.18
High: 1.2 Low: 1.17
Volume: 149,351 Market Cap: 69M
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 25 full-time employees. The firm is engaged in the discovery, development and delivery of medicines to treat diseases. The firm develops small molecule drugs that target disease pathways for potential applications in oncology. Its product candidate is duvelisib, also known as IPI-145, is an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K), for the treatment of hematologic malignancies, or blood cancers. The firm is also developing IPI-549, which is an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the gamma isoform of PI3K. In addition to duvelisib, the Company focuses to generate new product candidates for potential investigation in oncology. The firm also focuses on developing DYNAMO, CONTEMPO, BRAVURA, FRESCO, DYNAMO+R, DUO, SYNCHRONY and Duvelisib + Venetoclax.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.203 - 1.209 1.209 - 1.214
Low: 1.154 - 1.162 1.162 - 1.168
Close: 1.169 - 1.181 1.181 - 1.191

Technical analysis

as of: 2020-10-23 4:45:21 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.51     One year: 1.76
Support: Support1: 1.11    Support2:
Resistance: Resistance1: 1.29    Resistance2: 1.51
Pivot: 1.18
Moving Average: MA(5): 1.19     MA(20): 1.17
MA(100): 1.03     MA(250): 1.06
MACD: MACD(12,26): 0.02     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 41.67     %D(3): 46.88
RSI: RSI(14): 53.17
52-week: High: 1.68  Low: 0.60  Change(%): 9.3
Average Vol(K): 3-Month: 57376  10-Days: 28196

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
INFI has closed above bottom band by 48.1%. Bollinger Bands are 26.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 21 Oct 2020
Bulls Are Starting To Focus In On Infinity Pharmaceuticals, Inc. (INFI) - Invest Million

Thu, 15 Oct 2020
Reflecting on Infinity Pharmaceuticals’ (NASDAQ:INFI) Share Price Returns Over The Last Five Years - Simply Wall St

Sun, 11 Oct 2020
Would Shareholders Who Purchased Infinity Pharmaceuticals' (NASDAQ:INFI) Stock Five Years Be Happy With The Share price Today? - Yahoo Finance

Mon, 05 Oct 2020
Hot Stock Spotlight: Infinity Pharmaceuticals, (INFI) | Armenian American Reporter - Armenian Reporter

Wed, 30 Sep 2020
Why Infinity Pharmaceuticals Inc. (INFI) Is in Such Horrid Condition - The News Heater

Wed, 30 Sep 2020
Oppenheimer slashes price target on Infinity Pharmaceuticals Inc. [INFI] – find out why. - The DBT News

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 59
Shares Float (M) 36
% Held by Insiders 3.51
% Held by Institutions 50.64
Shares Short (K) 78
Shares Short P. Month (K) 149

Stock Financials

EPS -0.754
EPS Est This Year -0.920
EPS Est Next Year -1.500
Book Value (p.s.) -0.200
Profit Margin
Operating Margin -2889.71
Return on Assets (ttm) -44.4
Return on Equity (ttm) -474.7
Qtrly Rev. Growth 40.1
Gross Profit (p.s.) -0.533
Sales Per Share 0.024
EBITDA (p.s.) -0.698
Qtrly Earnings Growth
Operating Cash Flow (M) -38
Levered Free Cash Flow (M) -27

Stock Valuations

PE Ratio -1.56
PEG Ratio
Price to Book value -5.90
Price to Sales 48.24
Price to Cash Flow -1.83

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.